Construction of a postoperative survival nomogram for breast cancer based on ultrasound and cancer indicators

WU Xin; LIANG Bo

doi:10.7619/jcmp.20213928

Journal of Clinical Medicine in Practice > 2021 > 25(23): 62-68. > DOI: 10.7619/jcmp.20213928

WU Xin, LIANG Bo. Construction of a postoperative survival nomogram for breast cancer based on ultrasound and cancer indicators[J]. Journal of Clinical Medicine in Practice, 2021, 25(23): 62-68. DOI: 10.7619/jcmp.20213928

Citation:

PDF (3087 KB)

Construction of a postoperative survival nomogram for breast cancer based on ultrasound and cancer indicators

WU Xin¹,
LIANG Bo^2, ,

1.
Department of Medical Ultrasound, the Affiliated Hospital of Nantong University, Nantong, Jiangsu, 226001
2.
Department of Medical Ultrasound, Nantong City First People's Hospital of Jiangsu Province, Nantong, Jiangsu, 226000

More Information

Received Date: September 30, 2021
Available Online: December 06, 2021

Graphical Abstract

Abstract

Abstract

Objective
To investigate the prognostic factors of progression free survival (PFS) in patients with breast cancer, and to construct and validate prognosis nomogram model based on clinicopathological features, preoperative cancer indicators and ultrasound features.
Methods
Clinicopathological features, preoperative cancer indicators and ultrasound data of 260 breast cancer patients in the Affiliated Hospital of Nantong University from November 2011 to December 2015 after surgical treatment were analyzed retrospectively, and the Cox risk model was used to gradually determine the independent prognostic factors of PFS in breast cancer patients. A prediction model was established and conducted with internal validation.
Results
The results of multivariate Cox analysis showed that the largest diameter of tumor, lymph node metastasis, estrogen receptor (ER), carbohydrate antigen 125 (CA125), carbohydrate antigen 153 (CA153) and growth direction were the independent predictors of PFS (P < 0.05). A nomogram model was established based on the above indicators, and the validation results showed that the area under the curve of the receiver operating characteristic (ROC) curve for 5-year PFS was 0.844, and the C-index was 0.793 (95%CI, 0.736 to 0.850), and the 3- and 5-year calibration curves of the nomogram was close to the reference line and showed a good consistency.
Conclusion
In this study, we construct a prognostic prediction nomogram model that combines the clinicopathological features, preoperative cancer markers and ultrasonographic features to provide a visual survival assessment for breast cancer patients.
- breast cancer,
- ultrasound,
- prognosis,
- nomogram model,
- progression free survival,
- clinicopathological features

FullText(HTML)

References (23)

References

[1]	SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer Statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33. doi: 10.3322/caac.21654
[2]	赵港美, 章立楠. 乳腺癌患者术后复发转移的危险因素logistic回归分析[J]. 中国妇幼保健, 2021, 36(5): 1147-1149.
[3]	CIMINO-MATHEWS A. Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls[J]. Mod Pathol, 2021, 34(suppl 1): 62-77. http://www.nature.com/articles/s41379-020-00697-3
[4]	GUO Y, HU Y, QIAO M, et al. Radiomics analysis on ultrasound for prediction of biologic behavior in breast invasive ductal carcinoma[J]. Clin Breast Cancer, 2018, 18(3): e335-e344. doi: 10.1016/j.clbc.2017.08.002
[5]	DI GIOIA D, DRESSE M, MAYR D, et al. Serum HER2 in combination with CA 15-3 as a parameter for prognosis in patients with early breast cancer[J]. Clin Chim Acta, 2015, 440: 16-22. doi: 10.1016/j.cca.2014.11.001
[6]	MELICHAR B. Laboratory medicine and medical oncology: the tale of two Cinderellas[J]. Clin Chem Lab Med, 2013, 51(1): 99-112. doi: 10.1515/cclm-2012-0496
[7]	NGUYEN D, YU J, REINHOLD W C, et al. Association of independent prognostic factors and treatment modality with survival and recurrence outcomes in breast cancer[J]. JAMA Netw Open, 2020, 3(7): e207213. doi: 10.1001/jamanetworkopen.2020.7213
[8]	TANG J N, CUI Q X, ZHANG D, et al. An estrogen receptor (ER)-related signature in predicting prognosis of ER-positive breast cancer following endocrine treatment[J]. J Cell Mol Med, 2019, 23(8): 4980-4990. doi: 10.1111/jcmm.14338
[9]	SHAO Y, SUN X, HE Y, et al. Elevated levels of serum tumor markers CEA and CA15-3 are prognostic parameters for different molecular subtypes of breast cancer[J]. PLoS One, 2015, 10(7): e0133830. doi: 10.1371/journal.pone.0133830
[10]	UEHARA M, KINOSHITA T, HOJO T, et al. Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3(CA 15-3) in breast cancer[J]. Int J Clin Oncol, 2008, 13(5): 447-451. doi: 10.1007/s10147-008-0773-3
[11]	XU F, LIU F, ZHAO H, et al. Prognostic significance of mucin antigen MUC1 in various human epithelial cancers: a meta-analysis[J]. Medicine: Baltimore, 2015, 94(50): e2286. doi: 10.1097/MD.0000000000002286
[12]	LI J, LIU L, FENG Z, et al. Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study[J]. Breast Cancer, 2020, 27(4): 621-630. doi: 10.1007/s12282-020-01058-3
[13]	ZHANG J Y, WEI Q, DONG D, et al. The role of TPS, CA125, CA15-3 and CEA in prediction of distant metastasis of breast cancer[J]. Clin Chimica Acta, 2021, 523: 19-25. doi: 10.1016/j.cca.2021.08.027
[14]	LI X, DAI D, CHEN B, et al. Prognostic values of preoperative serum CEA and CA125 levels and nomograms for young breast cancer patients[J]. Onco Targets Ther, 2019, 12: 8789-8800. doi: 10.2147/OTT.S221335
[15]	REINARTZ S, FAILER S, SCHUELL T, et al. CA125(MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells[J]. Eur J Cancer, 2012, 48(10): 1558-1569. doi: 10.1016/j.ejca.2011.07.004
[16]	ZHAO S, MEI Y, WANG J, et al. Different levels of CEA, CA153 and CA125 in milk and benign and malignant nipple discharge[J]. PLoS One, 2016, 11(6): e0157639. doi: 10.1371/journal.pone.0157639
[17]	朱琳, 郑燕, 薛剑桥, 等. 常规超声联合超声造影对乳腺囊实性复合肿块良恶性的鉴别诊断价值[J]. 中华医学超声杂志: 电子版, 2020, 17(12): 1162-1167. doi: 10.3877/cma.j.issn.1672-6448.2020.12.003
[18]	PAN B, YAO R, ZHU Q L, et al. Clinicopathological characteristics and long-term prognosis of screening detected non-palpable breast cancer by ultrasound in hospital-based Chinese population (2001-2014)[J]. Oncotarget, 2016, 7(47): 76840-76851. doi: 10.18632/oncotarget.12319
[19]	CHAE E Y, MOON W K, KIM H H, et al. Association between ultrasound features and the 21-gene recurrence score assays in patients with oestrogen receptor-positive, HER2-negative, invasive breast cancer[J]. PLoS One, 2016, 11(6): e0158461. doi: 10.1371/journal.pone.0158461
[20]	DIALANI V, GAUR S, MEHTA T S, et al. Prediction of low versus high recurrence scores in estrogen receptor-positive, lymph node-negative invasive breast cancer on the basis of radiologic-pathologic features: comparison with oncotype DX test recurrence scores[J]. Radiology, 2016, 280(2): 370-378. doi: 10.1148/radiol.2016151149
[21]	WANG H, ZHAN W, CHEN W, et al. Sonography with vertical orientation feature predicts worse disease outcome in triple negative breast cancer[J]. Breast, 2020, 49: 33-40. doi: 10.1016/j.breast.2019.10.006
[22]	GUO Q, ZHANG L, DI Z, et al. Assessing Risk Category of Breast Cancer by Ultrasound Imaging Characteristics[J]. Ultrasound Med Biol, 2018, 44(4): 815-824. doi: 10.1016/j.ultrasmedbio.2017.12.001
[23]	杨韵贤, 李世梅, 姚继祎, 等. 美国癌症联合委员会第八版乳腺癌预后分期Ⅰ-Ⅲ期与肿物BI-RADS分类超声特征的关系[J]. 实用医学杂志, 2020, 36(22): 3140-3143. doi: 10.3969/j.issn.1006-5725.2020.22.022

[1]	WANG Yu, YANG Jixue, GUO Dianqu, LIU Wenbin. Relationships of expression of high mobility group box 1 protein and toll-like receptor 4 in patients with clinical characteristics of refractory epilepsy and their predictive value[J]. Journal of Clinical Medicine in Practice, 2024, 28(19): 68-72, 83. DOI: 10.7619/jcmp.20241965
[2]	ZHENG Junqi, LIU Xiangyan. Distribution of pulmonary infection pathogens after lung cancer chemotherapy and diagnostic values of serum cytokeratin 19 fragment antigen, high mobility group box 1 protein and soluble hemoglobin scavenger receptor[J]. Journal of Clinical Medicine in Practice, 2024, 28(14): 7-11. DOI: 10.7619/jcmp.20241847
[3]	ZHAO Congcong, QI Wenmei. Mechanism of Xueshuantong injection combined with intravenous thrombolysis with alteplase in treatment of patients with acute cerebral infarction based on high mobility group protein B1/Toll-like receptor 4 signaling pathway[J]. Journal of Clinical Medicine in Practice, 2024, 28(13): 41-46. DOI: 10.7619/jcmp.20234027
[4]	YU Xinran, FENG Bing. Prognostic value of ratio of monocyte to high-density lipoprotein combined with high mobility group protein B1 in patients with septic myocardial injury[J]. Journal of Clinical Medicine in Practice, 2023, 27(23): 86-90, 94. DOI: 10.7619/jcmp.20232314
[5]	GAO Jianying, CAO Wenjuan, GAO Yuan. Values of D-dimer, prealbumin and soluble triggering receptor expressed on myeloid cells-1 in diagnosing severe pneumonia in children[J]. Journal of Clinical Medicine in Practice, 2023, 27(7): 108-112. DOI: 10.7619/jcmp.20223481
[6]	CHEN Yanrong, LIU Yan, WANG Shan, ZHANG Jing. Expression characteristics and detection value of histamine, soluble myeloid cell trigger receptor-1, microribonuclease-145 and high-sensitivity C-reactive protein in patients with chronic obstructive pulmonary disease and coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 1-5. DOI: 10.7619/jcmp.20223161
[7]	MENG Chao, FAN Zhiqiang, TONG Qing, ZHU Guijun, ZHU Hui. Value of prognostic assessment of soluble triggering receptor expressed on myeloid cell-1, high-sensitivity C-reactive protein combined with the Acute Physiology and Chronic Health Evaluation Ⅱ score in patients with pneumonia complicated with respiratory failure[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 88-92, 101. DOI: 10.7619/jcmp.20211056
[8]	CAI Shaoying, YE Liling, ZHANG Pingheng, MAO Haifei, LIN Guoxiong. Effects of different anesthesia methods on postoperative cognitive function and high mobility group protein B1 for patients undergoing gastrointestinal surgery[J]. Journal of Clinical Medicine in Practice, 2021, 25(4): 41-44. DOI: 10.7619/jcmp.20201189
[9]	ZHANG Ye, ZHUANG Xueming, YU Dawei, XU Dongsheng, ZHANG Li, WANG Zhongxiang, WANG Shibo. Value of serum high mobility group box 1 combined with modified Edinburgh-Scandinavian Stroke Scale score in evaluating prognosis of acute ischemic stroke patients with intravenous thrombolysis[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 23-27. DOI: 10.7619/jcmp.20201140
[10]	LIU Ping, MEI Hong. Effect of low-dose hormone on serum soluble triggering receptor expressed on myeloid cells-1, procalcitonin and CD64 in children with sepsis[J]. Journal of Clinical Medicine in Practice, 2017, (15): 41-44,48. DOI: 10.7619/jcmp.201715011

Cited By

Cited by

Periodical cited type(13)

1.	鲍颍松，盛强，王珊，贾健安，童清平. 血清sTLT-1、ESM-1对ICU患者发生输血相关急性肺损伤的诊断价值. 检验医学与临床. 2025(01): 91-95 .
2.	张建新，马尚超，宋浩，殷飞，崔俊伟. 脓毒症患者血清HMGB1、sTLT-1、NLR变化及其对并发急性肺损伤的预测价值. 海南医学. 2024(12): 1736-1739 .
3.	李志丹，杨璐瑜，曹松，陆辉志. 血清HMGB1、TIMP-2水平与脓毒症急性肾损伤预后的相关性研究. 中国急救复苏与灾害医学杂志. 2024(07): 892-895 .
4.	曾玉龙，陈玲玲，陈相. 急性大出血患者血清CCL25和sTLT-1水平表达与输血相关性急性肺损伤发生的相关性研究. 现代检验医学杂志. 2024(04): 126-130 .
5.	沃琦，汪秀英，杜腾飞，冯棋佳，戴志春，朱静文. 急性感染性腹膜炎并发急性肺损伤外周血CXCR4和sTLT-1水平. 中华医院感染学杂志. 2024(22): 3408-3411 .
6.	王晓林，李静，范志强，佟庆，黄艳丽. 血清sTLT-1、SP-D、NF-κB水平在脓毒症急性肺损伤预后评估中的价值. 西部医学. 2024(12): 1781-1785 .
7.	李丹丹，张由建，靳津鸽. 血清相关细胞因子水平变化与急性心肌梗死患者 MACE风险的相关性研究. 医学理论与实践. 2023(10): 1726-1728 .
8.	焦相赟，吴金海，李翠英，李想. 脓毒血症合并急性肾损伤患者经CRRT联合血液灌注疗法治疗的疗效评价. 中国疗养医学. 2023(07): 759-762 .
9.	杜叶子，杨皓莹，段璠. 血清HMGB1、IL-33与再生障碍性贫血患儿病情严重程度及免疫状态的相关性分析. 国际检验医学杂志. 2023(16): 1949-1952+1957 .
10.	左扬松，周素芹，王丽莉，张玉凤，季擎天，王喆，李亚伟. 脓毒症相关急性肺损伤患者趋化因子受体4、可溶性髓样细胞触发受体样转录因子-1检测价值探讨. 实用医院临床杂志. 2023(06): 84-86 .
11.	刘瑞瑞，张树柳，王军芳，田昭涛，崔云亮. 乌司他丁对脓毒症大鼠肺损伤的保护作用及机制研究. 联勤军事医学. 2023(10): 827-830 .
12.	瞿红娟，万鲁云，桂春喜，王璐. 血清CXCR4和HMGB1水平在预测急性大出血患者输血相关性急性肺损伤预后中的价值研究. 临床和实验医学杂志. 2022(13): 1390-1393 .
13.	王慧，龚园其，周仪华，蓝海兵，张啸. 青藤碱调控Nrf2/Keap1信号通路对脓毒症急性肺损伤的改善作用. 实用医学杂志. 2022(15): 1896-1900 .

Other cited types(1)

Get Citation

PDF

XML

Article views (220) PDF downloads (22) Cited by(14)

Turn off MathJax

Article Contents

Abstract

References

Construction of a postoperative survival nomogram for breast cancer based on ultrasound and cancer indicators